(D) | 1. | ¥Ø«e½Ã¥Í¸p¤w®Öã¤@ºØ¤fªA¹TÓi»Ä¿EúC§í¨î¾¯¡]tyrosine kinase inhibitor¡^STI-571¡]¤SºÙGleevec©Îimtinib mesylate¡^¨Ï¥Î¦b¯e¯fªºªvÀø¤W¡A½Ð°Ý¤U¦C¨º¤@ºØ¯e¯f¥i¥H¥Î¦¹Ãıo¨ì¤£¿ùªº®ÄªG¡H |
A. | ±a¦³¬V¦âÅ鲧±`t(8;21)¤§«æ©Ê°©Åè©Ê¥Õ¦å¯f |
B. | ±a¦³¬V¦âÅ鲧±`inv(16)¤§«æ©Ê°©Åè©Ê¥Õ¦å¯f |
C. | ±a¦³¬V¦âÅ鲧±`t(4;11)¤§«æ©Ê²O¤ÚªÞ²ÓM¥Õ¦å¯f |
D. | ±a¦³¬V¦âÅ鲧±`t(9;22)¤§ºC©Ê°©Åè©Ê¥Õ¦å¯f |
E. | ±a¦³¬V¦âÅ鲧±`13q¤§ºC©Ê²O¤Ú²ÓM¥Õ¦å¯f |
|
(C) | 2. | ¤@65·³¯f±w¦]¬°µo¿N¦í°|¡A©â¦åÀˬdµo²{¥Õ¦å²y¼Æ¬°1,100/£gL¡Aneutrophils 10%¡Alymphocytes 80%¡Aeosinophils 1%¡A monocytes 9%¡A¬õ¦å²y¤Î¦å¤pªO¼Æ¥Ø¥¿±`¡C¯f¤H³ÌªñªA¥ÎªºÃĪ«¦p¤U¡A¨ä¤¤³Ì¥i¯à³y¦¨¦¹¦å²G¬ÛÅܤƪºÃĪ«¬O¨º¤@Ó¡H |
A. | Digoxin |
B. | Furosemide |
C. | Ticlopidine |
D. | Glipizide |
E. | Metformin |
|
(D) | 3. | ¤@¯f¤H¤W¸¡³¡¤£¾A¡A¸gGÃè¤Î¤Á¤ùÀˬdµo²{G¤º¦³MALT²O¤Ú½F¡]mucosa-associated lymphoid tumor¡^¡A¨ä¥LÀˬd¨ÃµL²§±`¡C½Ð°Ýªì¨B¹ï¦¹¯f¤H³Ì¾A·íªº³B¸m¬°¡G |
A. | G¤Á°£ |
B. | ©ñ®g½uªvÀø |
C. | ¤Æ¾ÇªvÀø |
D. | ¨Ï¥ÎªvÀø«Õªù±ìµßªºÃĪ« |
E. | G¤Á°£¥[©ñ®g½uªvÀø |
|
(B) | 4. | ¤@35·³°ü¤k¡AµL¥þ¨©Ê¯e±w¡A¦b¨Ò¦æÅéÀˮɡAµo²{¶gÃä¦å¤¤¦å¬õ¯À¬°10.2gm/dL¡AMCV¬°70fL¡A¥Õ¦å²y¤Î¦å¤pªO¼Æ¥¿±`¡C¯f¤H5¦~«eÅéÀˮɦå¬õ¯ÀȬ°12.5gm/dL¡AMCV¬°88fL¡C½Ð°Ý¦¹°ü¤k¥Ø«e³Ì¥i¯à¬O¦³¤°»ò¯f¡H |
A. | ®ü¬v©Ê³h¦å |
B. | ¯ÊÅK©Ê³h¦å |
C. | ¦A¥Í¤£¨}©Ê³h¦å |
D. | Vit B12¯Ê¥F©Ê³h¦å |
E. | ·»¦å©Ê³h¦å |
|
(A) | 5. | ¤U¦C±¡ªp³Ì¤£¥i¯à¤Þ°_¦å¤pªO¼Æ¥Ø°§CªÌ¬°¡G |
A. | ¨Ï¥Îepinephrine |
B. | ¨Ï¥Îheparin |
C. | ¨xµw¤Æ |
D. | ·»¦å©Ê§¿¬r¯gÔ¸s¡]hemolytic uremic syndrome¡^ |
E. | ¥þ¨©Ê¬õ´³©Ê¯T½H¡]systemic lupus erythematosus¡^ |
|
(B) | 6. | ¤@¯f¤Hªº°©Åè©Ù¤ù¦p¹Ï©Ò¥Ü¡A½Ð°Ý³o¦ì¯f¤H±o¤F¤°»ò¯f¡H |
A. | ºC©Ê°©Åè²ÓM¥Õ¦å¯f |
B. | «æ©Ê°©Åè©Ê¥Õ¦å¯f |
C. | ºC©Ê²O¤Ú²ÓM¥Õ¦å¯f |
D. | «æ©Ê²O¤ÚªÞ²ÓM¥Õ¦å¯f |
E. | ²O¤Ú½F°©Åè«I¥Ç |
|
(B) | 7. | §Ná¨H¾ý«~¡]cryoprecipitate¡^¤º§t¦³³¡¤À¾®¦å¦]¤l¡A¥i¥Î¨ÓªvÀø»Ýnªº¯f±w¡A¤U¦C¯f¤H¤¤¦óªÌ¨Ï¥Î§Ná¨H¾ý«~¨S¦³À°§U¡H |
A. | A«¬¦å¤Í¯f±w |
B. | B«¬¦å¤Í¯f±w |
C. | Von-Willebrand¤ó¯f±w |
D. | ÅÖºû³J¥Õì¡]fibrinogen¡^¯Ê¥F¯f±w |
E. | ÅÖºû³J¥Õ첧±`¯f±w |
|
(A) | 8. | ¤@25·³¯f¤H³Q¶EÂ_¬°«æ©Ê²O¤ÚªÞ²ÓM¥Õ¦å¯f¡A¶O«°¬V¦âÅ鶧©Ê¡C½Ð°Ý¹ï¦¹¯f¤H³Ì¾A·íªº³B¸m¬°¦ó¡H |
A. | ¦b¥S§Ì©n©f¤¤´M§ä¤HÃþ¥Õ¦å²y§Üì»P¯f¤H¬Û¦XªÌ¡A¦b¨Ï¥Î¤Æ¾ÇªvÀø¹F¨ì½w¸Ñ«á¡A§Y¶i¦æ²§Åé³y¦å·F²ÓM²¾´Ó¡C |
B. | ¨Ï¥Î¤Æ¾ÇªvÀø¹F¨ì½w¸Ñ«á¡A¶i¦æ¦ÛÅé³y¦å·F²ÓM²¾´Ó¡C |
C. | ¨Ï¥Î¤Æ¾ÇªvÀø¹F¨ì½w¸Ñ«á¡A¦A§@°ª¾¯¶q¥[±j©Ê¤Æ¾ÇªvÀø¡A®ÄªG»P³y¦å·F²ÓM²¾´Ó®t¤£¦h¡C |
D. | ¨Ï¥Î¤Æ¾ÇªvÀø¹F¨ì½w¸Ñ«á¡A¦A§ï¥Î¤fªAºû«ù©Ê¤Æ¾ÇªvÀø¡C |
E. | ¨Ï¥Î¤Æ¾ÇªvÀø¹F¨ì½w¸Ñ«á¡A¥i°±ÃıK¤Á°lÂÜ¡C |
|
(E) | 9. | ¤U¦C¨º¨Çì¦]¥i³y¦¨¦hµo©Ê°©Åè½F¯f¤HªºµÇŦ¥\¯à»Ùê¡H1. §K¬Ì²y³J¥Õ»´Ãì¡]light chain¡^¥Ñ¤p«K¤¤±Æ¥X2. °ª¶t¦å¯g3. °ª§¿»Ä¦å¯g4. Ãþ¾ý¯»¡]amyloid¡^¨H¿n |
A. | 1+2 |
B. | 1+3 |
C. | 2+3 |
D. | 1+2+3 |
E. | 1+2+3+4 |
|
(C) | 10. | «æ©Ê«e°©Åè²ÓM¥Õ¦å¯f¡]acute promyelocytic leukemia¡^¯f¤H¨Ï¥Î¥þ¤Ï¦¡ºû¥Ò»Ä¡]all-trans retinoic acid¡^ªvÀø«á¡A¦³¥i¯à¥X²{ºû¥Ò»Ä¯gÔ¸s¡]retinoic acid syndrome¡^½Ð°Ý¤U¦C¦óªÌ¬O¦¹¯gÔ¸s±`¨£ªº¯gª¬¡H1. µo¿N2. ªÍ®û¼í¤Þ°_©I§l«æ«P3. Åöíw |
A. | 1 |
B. | 2 |
C. | 1+2 |
D. | 1+3 |
E. | 2+3 |
|